Keywords: ucb, submits, pediatric, iv, keppra, filings, pharma

UCB submits pediatric and IV Keppra filings

Article | 10 January 2005

Print This

UCB Pharma has filed a supplemental New Drug Application with the US Food and Drug Administration for a pediatric indication ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in